C120H126F4N34O14 — CID 159433443
2-(2,3-dihydro-1-benzofuran-6-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;(4-fluorophenyl) N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]carbamate;2-methoxy-6-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(trifluoromethyl)benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-piperidin-1-ylpyridine-3-carboxamide (PubChem CID 159433443) has the molecular formula C120H126F4N34O14 and a molecular weight of 2344.54 g/mol. Its IUPAC name is 2-(2,3-dihydro-1-benzofuran-6-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;(4-fluorophenyl) N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]carbamate;2-methoxy-6-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(trifluoromethyl)benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-piperidin-1-ylpyridine-3-carboxamide.
| Compound Name | 2-(2,3-dihydro-1-benzofuran-6-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;(4-fluorophenyl) N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]carbamate;2-methoxy-6-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(trifluoromethyl)benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-piperidin-1-ylpyridine-3-carboxamide |
|---|---|
| PubChem CID | 159433443 |
| Molecular Formula | C120H126F4N34O14 |
| Molecular Weight | 2344.54 g/mol |
| Exact Mass | 2343.01 |
| IUPAC Name | 2-(2,3-dihydro-1-benzofuran-6-yl)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]acetamide;N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-1-pyrimidin-2-ylpiperidine-4-carboxamide;(4-fluorophenyl) N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]carbamate;2-methoxy-6-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-3-(trifluoromethyl)benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-piperidin-1-ylpyridine-3-carboxamide |
| SMILES | COc1c(C(F)(F)F)ccc(C)c1C(=O)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.COc1cc2nc(-c3[nH]ncc3NC(=O)C3CCN(c4ncccn4)CC3)[nH]c2cc1OC.O=C(Cc1ccc2c(c1)OCC2)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)Oc1ccc(F)cc1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1cccnc1N1CCCCC1 |
| InChI | InChI=1S/C26H30N8O2.C25H25F3N6O3.C25H26N6O3.C22H21FN6O3.C22H24N8O3/c35-26(19-5-4-8-27-25(19)34-9-2-1-3-10-34)31-22-16-28-32-23(22)24-29-20-7-6-18(15-21(20)30-24)17-33-11-13-36-14-12-33;1-14-3-5-16(25(26,27)28)22(36-2)20(14)24(35)32-19-12-29-33-21(19)23-30-17-6-4-15(11-18(17)31-23)13-34-7-9-37-10-8-34;32-23(13-16-1-3-18-5-8-34-22(18)12-16)27-21-14-26-30-24(21)25-28-19-4-2-17(11-20(19)29-25)15-31-6-9-33-10-7-31;23-15-2-4-16(5-3-15)32-22(30)27-19-12-24-28-20(19)21-25-17-6-1-14(11-18(17)26-21)13-29-7-9-31-10-8-29;1-32-17-10-14-15(11-18(17)33-2)27-20(26-14)19-16(12-25-29-19)28-21(31)13-4-8-30(9-5-13)22-23-6-3-7-24-22/h4-8,15-16H,1-3,9-14,17H2,(H,28,32)(H,29,30)(H,31,35);3-6,11-12H,7-10,13H2,1-2H3,(H,29,33)(H,30,31)(H,32,35);1-4,11-12,14H,5-10,13,15H2,(H,26,30)(H,27,32)(H,28,29);1-6,11-12H,7-10,13H2,(H,24,28)(H,25,26)(H,27,30);3,6-7,10-13H,4-5,8-9H2,1-2H3,(H,25,29)(H,26,27)(H,28,31) |
| InChIKey | LRGRNZLFDMZANM-UHFFFAOYSA-N |
| XLogP | 16.85 |
| TPSA | 573.48 Ų |
| H-Bond Donors | 15 |
| H-Bond Acceptors | 33 |
| Rotatable Bonds | 29 |
| Heavy Atoms | 172 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2344.54 |
| LogP ≤ 5 | 16.85 |
| H-Bond Donors ≤ 5 | 15 |
| H-Bond Acceptors ≤ 10 | 33 |